Atrial fibrillation pathophysiology: implications for management

Y Iwasaki, K Nishida, T Kato, S Nattel - Circulation, 2011 - Am Heart Assoc
Atrial fibrillation (AF), the most common sustained cardiac arrhythmia, is an important
contributor to population morbidity and mortality. An arrhythmia that is particularly common …

Recent advances in the molecular pathophysiology of atrial fibrillation

R Wakili, N Voigt, S Kääb, D Dobrev… - The Journal of clinical …, 2011 - Am Soc Clin Investig
Atrial fibrillation (AF) is an extremely common cardiac rhythm disorder that causes
substantial morbidity and contributes to mortality. The mechanisms underlying AF are …

Atrial fibrillation: current knowledge and future directions in epidemiology and genomics

JW Magnani, M Rienstra, H Lin, MF Sinner, SA Lubitz… - Circulation, 2011 - Am Heart Assoc
Atrial fibrillation (AF) is of public health importance and profoundly increases morbidity,
mortality, and healthrelated expenditures. Morbidities include the increased risks of …

Role of miR-21 in the pathogenesis of atrial fibrosis

O Adam, B Löhfelm, T Thum, SK Gupta, SL Puhl… - Basic research in …, 2012 - Springer
Atrial fibrosis is important for the pathogenesis of atrial fibrillation (AF) but the underlying
signal transduction is incompletely understood. We therefore studied the role of microRNA …

Atrial cardiomyopathy: pathophysiology and clinical consequences

A Goette, U Lendeckel - Cells, 2021 - mdpi.com
Around the world there are 33.5 million patients suffering from atrial fibrillation (AF) with an
annual increase of 5 million cases. Most AF patients have an established form of an atrial …

The multidimensional role of calcium in atrial fibrillation pathophysiology: mechanistic insights and therapeutic opportunities

S Nattel, D Dobrev - European heart journal, 2012 - academic.oup.com
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, and its prevalence is
increasing with the ageing of the population. Presently available treatment options are far …

[HTML][HTML] Extracellular/circulating microRNAs and their potential role in cardiovascular disease

H Zhu, GC Fan - American journal of cardiovascular disease, 2011 - ncbi.nlm.nih.gov
Abstract microRNAs (miRs, miRNAs) are small non-coding RNAs that regulate hundreds of
gene expression. Numerous studies have demonstrated that miRNAs are not only found …

Role for MicroRNA-21 in atrial profibrillatory fibrotic remodeling associated with experimental postinfarction heart failure

S Cardin, E Guasch, X Luo, P Naud… - Circulation …, 2012 - Am Heart Assoc
Background—Atrial tissue fibrosis is often an important component of the atrial fibrillation
(AF) substrate. Small noncoding microRNAs are important mediators in many cardiac …

microRNAs in cardiovascular disease–clinical application

C Schulte, M Karakas, T Zeller - Clinical Chemistry and Laboratory …, 2017 - degruyter.com
Abstract microRNAs (miRNAs) are well-known, powerful regulators of gene expression, and
their potential to serve as circulating biomarkers is widely accepted. In cardiovascular …

Regulation of the SK3 channel by microRNA-499—potential role in atrial fibrillation

TY Ling, XL Wang, Q Chai, TW Lau, CM Koestler… - Heart Rhythm, 2013 - Elsevier
BACKGROUND: MicroRNAs are important regulators of gene expression, including those
involving electrical remodeling in atrial fibrillation (AF). Recently, KCNN3, the gene that …